JAK-Inhibitor Review Delays Spur Talk Of US FDA Panel Meeting On Class Safety

 
• By Sue Sutter
  
Alarm clock
FDA reviews of new indications for JAK inhibitors are being slowed by safety concerns. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet